Hours of Operation
The CACF is currently open between 9am-5pm Monday through Friday but appointments are scheduled from 10-12 and 1-5pm.
Please contact Mary Price at email@example.com or 988-3442 to schedule appointments.
All new users must download, print, and fill in the Account Authorization Form, and bring it to the Facility with the signature of the principal investigator.
Scheduled Appointment Policy
Please notify Core personnel immediately if any information changes before your scheduled appointment.
Aria/LSR II Users
All users are requested to contact the facility at least two business days in advance for cell analysis or sorting. It is recommended to check the availability of the instrument before starting your experiment in order to ensure that samples will be run on time. Please contact the facility as soon as possible if any changes to your scheduled time is needed.
BD Pathway 855 Users
All users must submit a Pathway Protocol Information sheet and a 96 Well Plate template to the Cell Analysis Core prior to scheduling an appointment for the BD Pathway 855. Core personnel will review the completed Pathway Protocol Information sheet and contact users with instrument availability based on core personnel scheduling.
First Time User
Please contact Mary Price, prior to scheduling so that you can be assured that the facility is prepared to meet your needs and to expedite any special requests. Explain what you hope to achieve and we will help you to decide what instrumentation would most suit your needs. A brief consultation on experimental design to discuss controls needed and an introduction to sample preparation is required.
Feedback and Acknowledgments
We welcome any feedback from users of the Cell Analysis Core Facility. Please email any comments or suggestions directly to firstname.lastname@example.org or Prescott Deininger at email@example.com.
As a reminder, all users of the CACF are asked to acknowledge the Core in their papers. We would like the Core to be acknowledged as “The Louisiana Cancer Research Consortium FACS Core.” The Core is also supported through Dr. Prescott Deininger’s COBRE Grant. Please acknowledge this grant as well. Below is suggested wording for the COBRE grant acknowledgement:
Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number P20GM103518. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Please also send a copy of the paper or the PMID to Mary Price, senior research scientist, at firstname.lastname@example.org.